Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Teva
Deloitte
McKesson
Queensland Health
AstraZeneca
Daiichi Sankyo
Fish and Richardson
Colorcon
Healthtrust

Generated: October 20, 2017

DrugPatentWatch Database Preview

DEXTROSE 50% IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

Which patents cover Dextrose 50% In Plastic Container, and when can generic versions of Dextrose 50% In Plastic Container launch?

Dextrose 50% In Plastic Container is a drug marketed by Baxter Hlthcare, Hospira, and Icu Medical Inc. and is included in five NDAs.

The generic ingredient in DEXTROSE 50% IN PLASTIC CONTAINER is dextrose. There are eight drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the dextrose profile page.

Summary for Tradename: DEXTROSE 50% IN PLASTIC CONTAINER

US Patents:0
Applicants:3
NDAs:5
Suppliers / Packagers: see list5
Bulk Api Vendors: see list11
Clinical Trials: see list605
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DEXTROSE 50% IN PLASTIC CONTAINER at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare
DEXTROSE 50% IN PLASTIC CONTAINER
dextrose
INJECTABLE;INJECTION017521-001Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
Icu Medical Inc
DEXTROSE 50% IN PLASTIC CONTAINER
dextrose
INJECTABLE;INJECTION018563-001Mar 23, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
Hospira
DEXTROSE 50% IN PLASTIC CONTAINER
dextrose
INJECTABLE;INJECTION019445-001Jun 3, 1986RXYesNo► Subscribe► Subscribe► Subscribe
Baxter Hlthcare
DEXTROSE 50% IN PLASTIC CONTAINER
dextrose
INJECTABLE;INJECTION020047-001Jul 2, 1991APRXYesYes► Subscribe► Subscribe► Subscribe
Icu Medical Inc
DEXTROSE 50% IN PLASTIC CONTAINER
dextrose
INJECTABLE;INJECTION019894-001Dec 26, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
McKesson
Colorcon
Moodys
Covington
Cipla
Cantor Fitzgerald
Chinese Patent Office
Mallinckrodt
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot